Taraxasterol (cas 1059-14-9) inhibits cigarette smoke-induced lung inflammation by inhibiting reactive oxygen species-induced TLR4 trafficking to lipid rafts
-
Add time:07/28/2019 Source:sciencedirect.com
Taraxasterol (cas 1059-14-9), a pentacyclic-triterpene isolated from Taraxacum officinale, has been demonstrated to have anti-inflammatory effects. However, the protective effects of taraxasterol against cigarette smoke (CS)-induced lung inflammation have not been reported. This study aimed to investigate the protective effects and mechanism of taraxasterol on CS-induced lung inflammation in mice. CS-induced mouse lung inflammation model was used to investigate the protective effects of taraxasterol in vivo. Human bronchial epithelial cells (HBECs) were used to investigate the protective mechanism of taraxasterol in vitro. The results showed that taraxasterol attenuated CS-induced lung pathological changes, inflammatory cells infiltration, inflammatory cytokines TNF-α, IL-6 and IL-1β production. Taraxasterol also up-regulated CS-induced glutathione (GSH) production. In vitro, taraxasterol was found to inhibit CS-induced reactive oxygen species production, recruitment of TLR4 into lipid rafts, NF-κB activation, and IL-8 production. Furthermore, our results showed that antioxidant N-acetyl-L-cysteine (NAC) significantly inhibited CS-induced recruitment of TLR4 into lipid rafts as well as IL-8 production. In conclusion, our results suggested that taraxasterol had protective effects of CS-induced lung inflammation.
We also recommend Trading Suppliers and Manufacturers of Taraxasterol (cas 1059-14-9). Pls Click Website Link as below: cas 1059-14-9 suppliers
Prev:Taraxasterol (cas 1059-14-9) inhibits IL-1β-induced inflammatory response in human osteoarthritic chondrocytes
Next:Effects of Taraxasterol (cas 1059-14-9) on ovalbumin-induced allergic asthma in mice) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Optimization of methyl jasmonate and β-cyclodextrin for enhanced production of taraxerol and Taraxasterol (cas 1059-14-9) in (Taraxacum officinale Weber) cultures08/02/2019
- Effects of Taraxasterol (cas 1059-14-9) on iNOS and COX-2 expression in LPS-induced RAW 264.7 macrophages08/01/2019
- Effects of Taraxasterol (cas 1059-14-9) on inflammatory responses in lipopolysaccharide-induced RAW 264.7 macrophages07/31/2019
- Protective effect of Taraxasterol (cas 1059-14-9) on acute lung injury induced by lipopolysaccharide in mice07/30/2019
- Effects of Taraxasterol (cas 1059-14-9) on ovalbumin-induced allergic asthma in mice07/29/2019
- Taraxasterol (cas 1059-14-9) inhibits IL-1β-induced inflammatory response in human osteoarthritic chondrocytes07/27/2019
- Anti-inflammatory and anti-arthritic effects of Taraxasterol (cas 1059-14-9) on adjuvant-induced arthritis in rats07/26/2019
- Taraxasterol (cas 1059-14-9) suppresses inflammation in IL-1β-induced rheumatoid arthritis fibroblast-like synoviocytes and rheumatoid arthritis progression in mice07/25/2019
- Network pharmacology-based identification of the protective mechanisms of Taraxasterol (cas 1059-14-9) in experimental colitis07/24/2019